Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 83.76% is 3723% above its 5-year average of 2.19%, near the high end of its 5-year range (0.20%–83.76%).
As of the fiscal period ended Tuesday, June 30, 2026. 46.89% above its 12-month average of 57.02%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 83.76%.
DEBT TO ASSETS RATIO
83.76%
DEBT TO ASSETS RATIO AVG TTM
57.02%
DEBT TO ASSETS RATIO AVG 3Y
25.77%
DEBT TO ASSETS RATIO AVG 5Y
2.19%
DEBT TO ASSETS RATIO AVG 10Y
2.20%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+46.89%
CURRENT VS 3Y AVG
+225.02%
CURRENT VS 5Y AVG
+3722.59%
CURRENT VS 10Y AVG
+3708.39%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+92967.15%
vs the sector median at left
Syndax Pharmaceuticals, Inc.
Market Cap
$1.54B
Debt to Assets Ratio
83.76%
TTM Avg
57.02%
3Y Avg
25.77%
5Y Avg
2.19%
Market Cap
$1.57B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.50B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.59B
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.49B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.48B
Debt to Assets Ratio
0.53%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals, Inc. (SNDX) | $1.54B | 83.76% | 57.02% | 25.77% | 2.19% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 0.16% | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | 0.01% | N/A | N/A | N/A |
| Nutex Health, Inc. (NUTX)vs › | $1.50B | 0.36% | N/A | N/A | N/A |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 0.25% | N/A | N/A | N/A |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | 0.22% | N/A | N/A | N/A |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | 0.02% | N/A | N/A | N/A |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 0.53% | N/A | N/A | N/A |
| uniQure N.V. (QURE)vs › | $1.60B | 0.06% | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.48B | 0.00% | N/A | N/A | N/A |
Debt/Assets
83.8%
Debt/Equity
39.03
Current Ratio
6.77
Interest Coverage
-8.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 83.76% |
| 2026-03-31 | 73.07% |
| 2025-12-31 | 65.41% |
| 2025-09-30 | 62.60% |
| 2025-06-30 | 0.28% |
| 2025-03-31 | 0.29% |
| 2024-12-31 | 47.70% |
| 2024-09-30 | 0.20% |
| 2024-06-30 | 0.24% |
| 2024-03-31 | 0.26% |
| 2023-12-31 | 0.27% |
| 2023-09-30 | 0.47% |
| 2023-06-30 | 0.49% |
| 2023-03-31 | 0.23% |
| 2022-12-31 | 0.23% |
| 2022-09-30 | 0.35% |
| 2022-06-30 | 5.19% |
| 2022-03-31 | 4.98% |
| 2021-12-31 | 4.66% |
| 2021-09-30 | 9.04% |
| 2021-06-30 | 7.90% |
| 2021-03-31 | 7.43% |
| 2020-12-31 | 6.83% |
| 2020-09-30 | 11.46% |
| 2020-06-30 | 10.67% |
| 2020-03-31 | 19.57% |
| 2019-12-31 | 1.41% |
| 2019-09-30 | 1.31% |
| 2019-06-30 | 1.44% |
| 2019-03-31 | 1.36% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 7.95% |
| 2014-12-31 | 108.33% |
| 2014-09-30 | 79.64% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 27.72% |
| 2012-12-31 | 0.00% |
